Polychemotherapy in combination with thalidomide followed by autologous or allogeneic transplantation for rescue after autograft or induction therapy failure in patients with multiple myeloma.

被引：0
|
作者：
Hegenbart, Ute
Schonland, Stefan O.
Moehler, Thomas
Benner, Axel
Gerull, Sabine
Goerner, Martin
Schaefer, Hans-Joerg
Egerer, Gerlinde
Dreger, Peter
ho, Antny D. Ho
Goldschmidt, Hartmut
机构：
[1] Univ Heidelberg, Dept Med 5, Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3018.3018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3018
引用
收藏
页码：856A / 857A
页数：2
相关论文
共 50 条
  • [1] Second autologous or allogeneic transplantation after the failure of first autograft in multiple myeloma.
    Qazilbash, MH
    Saliba, R
    de Lima, M
    Couriel, D
    Hosing, C
    Aleman, A
    Lei, X
    Champlin, RE
    Giralt, SA
    BLOOD, 2004, 104 (11) : 909A - 909A
  • [2] Salvage Autologous or Allogeneic Stem Cell Transplantation After the Failure of First Autograft in Patients with Multiple Myeloma.
    Bashir, Qaiser
    Thall, Peter
    Hosing, Chitra
    Mendoza, Floralyn L.
    Han, Eric
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Anderlini, Paolo
    Kebriaei, Partow
    Khouri, Issa F.
    Popat, Uday
    de Lima, Marcos
    Champlin, Richard
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    BLOOD, 2009, 114 (22) : 487 - 487
  • [3] Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma
    Qazilbash, MH
    Saliba, R
    De Lima, M
    Hosing, C
    Couriel, D
    Aleman, A
    Roden, L
    Champlin, R
    Giralt, SA
    CANCER, 2006, 106 (05) : 1084 - 1089
  • [4] Thalidomide as rescue treatment of relapses after haematopoietic transplantation in multiple myeloma.
    Alegre, A
    Macías, GR
    Granda, A
    Golbano, N
    Martínez, E
    Aláez, C
    Blázquez, C
    Góngora, E
    Cannata, J
    Sánchez-Godoy, P
    Martínez-Chamorro, C
    Arranz, R
    de Soria, VGG
    Figuera, A
    Arranz, E
    Fernández-Rañada, JM
    BLOOD, 2001, 98 (11) : 307B - 307B
  • [5] Primary therapy with thalidomide and dexamethasone in preparation to autologous transplantation for multiple myeloma.
    Cavo, M
    Zamagni, E
    Tosi, P
    Cellini, C
    de Vivo, A
    Cangini, D
    Tonelli, M
    Testoni, N
    Grafone, T
    Tacchetti, P
    Soverini, S
    Terragna, C
    Tura, S
    Baccarani, M
    BLOOD, 2003, 102 (11) : 448A - 448A
  • [6] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BLOOD, 2003, 102 (11) : 489B - 490B
  • [7] Therapy with thalidomide enhances overall survival after autologous PBSC transplant for multiple myeloma.
    Brinker, B
    Waller, EK
    Langston, AA
    Redei, I
    Smith, KJ
    Bucur, SZ
    Winton, E
    Lyles, R
    Heffner, LT
    Lonial, S
    BLOOD, 2002, 100 (11) : 178A - 178A
  • [8] Thalidomide as maintenance therapy in the post-transplantation setting in patients with multiple myeloma.
    Santos, E
    Goodman, M
    Byrnes, JJ
    Fernandez, HF
    BLOOD, 2002, 100 (11) : 426B - 426B
  • [9] Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.
    Martinelli, GG
    Terragna, CC
    Zamagni, EE
    Ronconi, SS
    Tosi, PP
    Lemoli, RMRM
    Bandini, GG
    Motta, MRMR
    Testoni, NN
    Amabile, MM
    Ottaviani, EE
    Vianelli, NN
    de Vivo, AA
    Gozzetti, AA
    Tura, SS
    Cavo, MM
    BLOOD, 2000, 96 (11) : 152A - 153A
  • [10] Molecular monitoring of minimal residual disease after autologous or allogeneic transplantation for multiple myeloma.
    Corradini, P
    Tarella, C
    Astolfi, M
    Voena, C
    Ladetto, M
    Majolino, I
    Bacigalupo, A
    Boccadoro, M
    Pileri, A
    BLOOD, 1996, 88 (10) : 2464 - 2464
12345